Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5)

被引:26
|
作者
Palte, Rachel L. [1 ]
Schneider, Sebastian E. [1 ]
Altman, Michael D. [1 ]
Hayes, Robert P. [2 ]
Kawamura, Shuhei [1 ]
Lacey, Brian M. [1 ]
Mansueto, My Sam [1 ]
Reutershan, Michael [1 ]
Siliphaivanh, Phieng [1 ]
Sondey, Christopher [1 ]
Xu, Haiyan [1 ]
Xu, Zangwei [1 ]
Ye, Yingchun [1 ]
Machacek, Michelle R. [1 ]
机构
[1] Merck & Co Inc, Computat & Struct Chem, Boston, MA 02115 USA
[2] Computat & Struct Chem, West Point, PA 19486 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2020年 / 11卷 / 09期
关键词
PRMT5; allosteric inhibition; methyltransferase; peptide competitive; SAM competitive; crystal structure; SELECTIVE INHIBITOR; METHYLATION; POTENT; DISCOVERY; DELETION; HISTONE;
D O I
10.1021/acsmedchemlett.9b00525
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Protein arginine methyltransferase 5 (PRMT5) belongs to a family of enzymes that regulate the posttranslational modification of histones and other proteins via methylation of arginine. Methylation of histones is linked to an increase in transcription and regulates a manifold of functions such as signal transduction and transcriptional regulation. PRMT5 has been shown to be upregulated in the tumor environment of several cancer types, and the inhibition of PRMT5 activity was identified as a potential way to reduce tumor growth. Previously, four different modes of PRMT5 inhibition were known-competing (covalently or non-covalently) with the essential cofactor Sadenosyl methionine (SAM), blocking the substrate binding pocket, or blocking both simultaneously. Herein we describe an unprecedented conformation of PRMT5 in which the formation of an allosteric binding pocket abrogates the enzyme's canonical binding site and present the discovery of potent small molecule allosteric PRMT5 inhibitors.
引用
收藏
页码:1688 / 1693
页数:6
相关论文
共 50 条
  • [31] Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization
    Mao, Ruifeng
    Shao, Jingwei
    Zhu, Kongkai
    Zhang, Yuanyuan
    Ding, Hong
    Zhang, Chenhua
    Shi, Zhe
    Jiang, Hualiang
    Sun, Dequn
    Duan, Wenhu
    Luo, Cheng
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (14) : 6289 - 6304
  • [32] Arginine methyltransferase PRMT5 negatively regulates cGAS-mediated antiviral immune response
    Ma, Dapeng
    Yang, Min
    Wang, Qiushi
    Sun, Caiyu
    Shi, Hongbiao
    Jing, Weiqiang
    Bi, Yuxuan
    Shen, Xuecheng
    Ma, Xiaomin
    Qin, Zhenzhi
    Lin, Yueke
    Zhu, Lihui
    Zhao, Yunxue
    Cheng, Yeping
    Han, Lihui
    SCIENCE ADVANCES, 2021, 7 (13)
  • [33] Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling
    Chung, Jihyun
    Karkhanis, Vrajesh
    Baiocchi, Robert A.
    Sif, Said
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (19) : 7692 - 7710
  • [34] PRMT5 function and targeting in cancer
    Kim, Hyungsoo
    Ronai, Ze'ev A.
    CELL STRESS, 2020, 4 (08) : 199 - 215
  • [35] Protein Arginine Methyltransferase PRMT5 Regulates Fatty Acid Metabolism and Lipid Droplet Biogenesis in White Adipose Tissues
    Jia, Zhihao
    Yue, Feng
    Chen, Xiyue
    Narayanan, Naagarajan
    Qiu, Jiamin
    Syed, Sabriya A.
    Imbalzano, Anthony N.
    Deng, Meng
    Yu, Peng
    Hu, Changdeng
    Kuang, Shihuan
    ADVANCED SCIENCE, 2020, 7 (23)
  • [36] Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations
    Zhu, Kongkai
    Jiang, Chengshi
    Tao, Hongrui
    Liu, Jingqiu
    Zhang, Hua
    Luo, Cheng
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1476 - 1483
  • [37] Proteomics profiling of arginine methylation defines PRMT5 substrate specificity
    Musiani, Daniele
    Bok, Jabez
    Massignani, Enrico
    Wu, Liling
    Tabaglio, Tommaso
    Ippolito, Marica Rosaria
    Cuomo, Alessandro
    Ozbek, Umut
    Zorgati, Habiba
    Ghoshdastider, Umesh
    Robinson, Robert C.
    Guccione, Ernesto
    Bonaldi, Tiziana
    SCIENCE SIGNALING, 2019, 12 (575)
  • [38] The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells
    Li, Mingyue
    An, Wentao
    Xu, Linyan
    Lin, Yidan
    Su, Ling
    Liu, Xiangguo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [39] Protein arginine methyltransferase 5 (PRMT5) activates WNT/β-catenin signalling in breast cancer cells via epigenetic silencing of DKK1 and DKK3
    Shailesh, Harshita
    Siveen, Kodappully S.
    Sif, Said
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (03) : 1583 - 1600
  • [40] Computational Study of Symmetric Methylation on Histone Arginine Catalyzed by Protein Arginine Methyltransferase PRMT5 through QM/MM MD and Free Energy Simulations
    Yue, Yufei
    Chu, Yuzhuo
    Guo, Hong
    MOLECULES, 2015, 20 (06) : 10032 - 10046